Cargando…
IL-37 Plays a Beneficial Role in Patients with Acute Coronary Syndrome
BACKGROUND: Interleukin-37 (IL-37) acts as an inhibitor of innate and adaptive immunity. However, the exact role of IL-37 in the patients with acute coronary syndrome (ACS) remains to be elucidated. METHODS: Patients were classified into 4 groups: normal coronary artery (NCA), stable angina (SA), un...
Autores principales: | Mao, Xiaobo, Zhu, Ruirui, Zhang, Fangyuan, Zhong, Yucheng, Yu, Kunwu, Wei, Yuzhen, Sun, Haitao, Xu, Wenbin, Luo, Quan, Wang, Yue, Ding, Yan, Zeng, Qiutang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803729/ https://www.ncbi.nlm.nih.gov/pubmed/31686988 http://dx.doi.org/10.1155/2019/9515346 |
Ejemplares similares
-
Role of IL-37- and IL-37-Treated Dendritic Cells in Acute Coronary Syndrome
por: Zhu, Ruirui, et al.
Publicado: (2021) -
Interleukin‐37 and Dendritic Cells Treated With Interleukin‐37 Plus Troponin I Ameliorate Cardiac Remodeling After Myocardial Infarction
por: Zhu, Ruirui, et al.
Publicado: (2016) -
Interleukin‐38 alleviates cardiac remodelling after myocardial infarction
por: Wei, Yuzhen, et al.
Publicado: (2019) -
Lanatoside C Promotes Foam Cell Formation and Atherosclerosis
por: Shi, Huairui, et al.
Publicado: (2016) -
Elevated Plasma IL-37, IL-18, and IL-18BP Concentrations in Patients with Acute Coronary Syndrome
por: Ji, Qingwei, et al.
Publicado: (2014)